SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARADIGM CORP. ARDM -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (214)8/26/2004 1:12:42 PM
From: tuck  Read Replies (1) | Respond to of 255
 
No, though that struck me, too. I don't know why KOSP is targeting those parameters. If they've been measured for competing systems, I haven't been able to find any data or even mention of it. What struck me as more crucial was the "excipient-free" formulation. Wondering if AERx and Exubera use excipients that might cause those pulmonary problems. Don't think that relates directly to AERx' night time glucose level issues, though.

Cheers, Tuck